CSIMarket Company Name, Ticker, Customers, else..
 
Solventum Corporation  (NYSE: SOLV)
 
Price: $91.0600 $-0.06 -0.066%
Day's High: $91.63999938964844 Week Perf: -0.6 %
Day's Low: $ 90.30 30 Day Perf: 6.58 %
Volume (M): 926,320 52 Wk High: $ 92.71
Volume (M$): $ 0 52 Wk Avg: $76.02
Open: $90.33 52 Wk Low: $62.38



 Market Capitalization (Millions $) 15,981
 Shares Outstanding (Millions) 176
 Employees 20,000
 Revenues (TTM) (Millions $) 8,262
 Net Income (TTM) (Millions $) 1,432
 Cash Flow (TTM) (Millions $) 21
 Capital Exp. (TTM) (Millions $) 354

Business Description


Solventum Corporation is a global healthcare company that develops, manufactures, and commercializes healthcare solutions utilizing material science, data science, and digital technologies. The company operates through three segments: MedSurg, which provides wound therapy and surgical supplies; Dental Solutions, offering dental and orthodontic products; and Health Information Systems, delivering healthcare software aimed at enhancing revenue cycle management and clinician productivity. Solventum emphasizes research and development and maintains customer relationships to support patient care and healthcare standards.


   Company Address: 1750 Yankee Doodle Road Eagan 55121 MN
   Company Phone Number: 733-1110   Stock Exchange / Ticker: NYSE SOLV


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stock Market Announcement

Trian Fund Management Weighs in on Solventums Strategic Sale: Shareholder Implications and Board Evolution

Published Wed, Feb 26 2025 7:51 PM UTC

In a significant development for Solventum Corporation (NYSE: SOLV), Trian Fund Management, L.P. which holds approximately 5% of the company s shares, has publicly responded to the recent decision by Solventum to divest its Purification and Filtration business to Thermo Fisher Scientific Inc. (NYSE: TMO). As the largest active shareholder in the company, Trian s commentary u...
Personnel Announcements

Solventum Strengthens Board of Directors with Appointment of Shirley Edwards

Published Mon, Apr 15 2024 10:30 AM UTC


St. Paul, Minn., April 15, 2024 - Solventum, a leading global company in the financial sector, recently made a remarkable move by appointing Shirley Edwards, a former partner at EY, to its Board of Directors. Edwards brings extensive expertise and a wealth of experience to the company, further enhancing Solventum s strategic vision and commitment to excellence.
Effe...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 11.17
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.93
Price to Sales (Expected) -
Price to Book 3.22
PEG (TTM) 0.04

Financial Strength Current
Quick Ratio 0.29
Working Capital Ratio 1.71
Leverage Ratio (MRQ) 1.84
Total Debt to Equity 1.12
Interest Coverage (TTM) 8.17
Debt Coverage (TTM) 0.42

Per Share Current
Earnings (TTM) 8.16 $
Revenues (TTM) 47.08 $
Cash Flow (TTM) 0.12 $
Cash 3.2 $
Book Value 28.31 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 413,100
Net Income per Employee (TTM) 71,600
Receivable Turnover Ratio (TTM) 7.91
Inventory Turnover Ratio (TTM) 3.23
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) 54.66 %
Operating Margin (MRQ) 4.04 %
Net Margin (MRQ) 0.65 %
Net Cash Flow Margin (MRQ) -15.84 %
Effective Tax Rate (TTM) 15.32 %

Management Effectiveness Current
Return On Assets (TTM) 9.8 %
Return On Investment (TTM) 11.19 %
Return On Equity (TTM) 30.71 %
Dividend Yield -
Pay out Ratio (TTM) -



Solventum's Segments
All Other    3.79 % of total Revenue
MedSurg    61.48 % of total Revenue
MedSurg Advanced Wound Care    24.76 % of total Revenue
MedSurg Infection Prevention and Surgical Solutions    36.72 % of total Revenue
Dental Solutions    17.64 % of total Revenue
Health Information Systems    17.04 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.